Product
Tenofovir/Emtricitabine
1 clinical trial
1 indication
Indication
HIVClinical trial
A 48-Week, Randomized, Open-Label Phase 3B Study Comparing the Antiviral Efficacy and Safety of ATV/RTV 3TC With ATV/RTV Plus TDF/FTC In HIV-1-Infected, Treatment-Naïve Subjects, Followed By a 48-Week Period on ATV/RTV Plus 3TCStatus: Terminated, Estimated PCD: 2013-01-22